Anticoagulation-Amplified Recurrent Esophageal Hemorrhage in Triple-Positive Antiphospholipid Syndrome: The Inescapable Anticoagulation Dilemma
Case Reports in Gastroenterology · 05.06.2026 · 20 (1) · 266-275
DOI: 10.1159/000552878 ↗Kurz gefasst
Fallbericht in der Zeitschrift Case Reports in Gastroenterology, online erschienen am 05.06.2026. Verfasst von Akram Alnounou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Western Michigan University Homer Stryker M.D. School of Medicine, Kalamazoo, MI, USA. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Antiphospholipid syndrome (APS) is an acquired thrombophilia. Triple-positive APS, defined by lupus anticoagulant, anticardiolipin, and anti-β2-glycoprotein I antibody positivity, usually requires long-term vitamin K antagonist therapy; direct oral anticoagulants are discouraged, and low-molecular-weight heparin is reserved for selected situations. Case Presentation: A 52-year-old female with systemic lupus erythematosus and triple-positive APS on warfarin (International Normalized Ratio [INR] 2.9) presented with massive hematemesis requiring intubation. Serial esophagogastroduodenoscopy showed extensive esophageal clot burden followed by circumferential friability, sloughing, and necrotic/exudative esophagitis without varices or gastric/duodenal bleeding. Hemostatic powder was applied, fresh frozen plasma partially corrected the INR to 1.8, and anticoagulation was held. Therapeutic heparin bridging on hospital day 8 was followed by recurrent melena, hemoglobin decline from 8.3 to 5.5 g/dL, and gross hematuria; INR at rebleeding was 2.2. Hematology evaluation showed factor VIII activity 87% and negative Bethesda assay, arguing against acquired hemophilia A. Repeat endoscopy showed Los Angeles grade C esophagitis with clean-based linear ulcers and a 7-cm sliding hiatal hernia.
Conclusion
Severe diffuse esophageal mucosal injury can cause recurrent major bleeding when anticoagulation is resumed before mucosal recovery. In high-risk APS, anticoagulation resumption should be individualized with hematology and gastroenterology input, and repeat endoscopy may help guide timing.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Western Michigan University Homer Stryker M.D. School of Medicine, Kalamazoo, MI, USA.
Zitieren
APA
Alnounou, A., Zambrano, C., Ganguly, A., & Boamah, H. (2026). Anticoagulation-Amplified Recurrent Esophageal Hemorrhage in Triple-Positive Antiphospholipid Syndrome: The Inescapable Anticoagulation Dilemma. Case Reports in Gastroenterology, 20(1), 266-275. https://doi.org/10.1159/000552878
Vancouver
Alnounou A, Zambrano C, Ganguly A, Boamah H. Anticoagulation-Amplified Recurrent Esophageal Hemorrhage in Triple-Positive Antiphospholipid Syndrome: The Inescapable Anticoagulation Dilemma. Case Reports in Gastroenterology. 2026;20(1):266-275. doi:10.1159/000552878
BibTeX
@article{Alnounou2026,
author = {Alnounou, Akram and Zambrano, Chelsea and Ganguly, Arghyadeep and Boamah, Harry},
title = {Anticoagulation-Amplified Recurrent Esophageal Hemorrhage in Triple-Positive Antiphospholipid Syndrome: The Inescapable Anticoagulation Dilemma},
journal = {Case Reports in Gastroenterology},
year = {2026},
volume = {20},
number = {1},
pages = {266--275},
doi = {10.1159/000552878}
}
EUVIMED